Jland Biotech Co in Jingjiang Economic and Technological Development Zone. [Photo/WeChat ID: ZGJJKFQ]
The Jingjiang Economic and Technological Development Zone of Jingjiang, Taizhou city in Jiangsu province, East China, has intensified its efforts to compete in the biomedical industry sector over recent years.
Jland Biotech, located in Jingjiang ETDZ's Precision Manufacturing Industrial Park, stands as a national leader in delivering comprehensive integrated original design manufacturing services for a diverse range of recombinant collagen-based cosmeceutical products across the entire industrial chain.
Its clients include well-known domestic and international cosmetics brands, pharmaceutical firms, and medical aesthetics companies such as Estée Lauder, Osm, Sinopharm, and Chlitina.
In May, the company initiated operations of its cosmetics production line, which currently includes 12 production lines dedicated to cream-emulsions and freeze-dried products. The medical device manufacturing facilities also completed provincial licensing inspections on Aug 1. These facilities are now poised to commence the production of medical dressings and freeze-dried Class II medical devices, with an anticipated start date in late September.
When operating at full capacity, each production line for cosmetics will yield 100 million items annually.